Decision: Favourable

Study Title:

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients with IgA Nephropathy at Risk of Progressive Loss of Renal Function (The ALIGN Study)

  • NREC Code:


  • Decision:


  • Meeting Date:


  • Study Type:

    CT application

  • Principal Investigator:

    Dr Michelle Marie O'Shaughnessy

  • PI Institution:

    Cork University Hospital

  • Sponsor:

    Biotech company

Scroll to Top
Skip to content